Adenocarcinoma of the Rectum Completed Phase 1 Trials for Resveratrol (DB02709)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00433576Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By SurgeryTreatment